Therapeutic Area Partner (TAP) at Bristol-Myers Squibb

Israel

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Previous marketing experience
Strong strategic thinking and project management skills
Ability to stay up-to-date on product/indication-related data
Knowledge of regulatory standards and BMS SOPs for managing unsolicited off-label inquiries
Capability to provide accurate, balanced, and scientifically sound information on off-label uses

Responsibilities

Deliver results aligned with Oncology brands and company goals, ensuring commercial success
Prepare, coordinate, and execute Brand Plan and Tactical Plan, liaising cross-functionally with local teams (medical, field access, sales)
Lead brand strategy and drive marketing activities across all functions to achieve results
Assess and analyze the marketplace to understand internal and external environments
Analyze data from various sources to shape brand decisions and develop business plans
Engage in marketing projects from start to finish, including company events and congress participation
Leverage innovative channels to target customer segments
Provide field support, engage with HCPs, seek feedback following Oncology activities, and develop action plans
Build relationships with all functions impacted by the business environment (internal and external) and participate in Brand Team meetings
Build and maintain a robust business environment for BMS in Oncology, collaborating with marketing, medical, and market access teams
Actively support the field force to ensure flawless plan implementation and fulfillment of commitments
Manage and respond to unsolicited off-label inquiries from HCPs in compliance with regulations and BMS SOPs
Provide accurate and balanced information on off-label uses, referring complex inquiries to medical teams
Stay informed about latest research and developments related to off-label uses

Skills

Oncology

Brand Strategy

Project Management

Marketing

Cross-functional Collaboration

Regulatory Compliance

Off-label Inquiries

Brand Plan Execution

Tactical Planning

HCP Communication

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free